Odette Wegwarth - Publications

Abels, W., Reinhardt, K., Neugebauer, E., Wulkotte, E., Toubekis, E., Piedmont, S., Born, S., Rieck, T., Wegwarth, O., Spies, C., Schlattmann, P., Schwarzkopf, D., & Fleischmann-Struzek, C. (2024). Improving prevention and early detection of sepsis among patient groups at risk: Introducing a model for a multimodal information campaign. The SepWiss study protocol. PLoS ONE, 19(7), Article e0305107. https://doi.org/10.1371/journal.pone.0305107

Amelunxen, C., Bielecki, M., Wegwarth, O., & Funk, G.-C. (2024). The evidence effect: How fact boxes shift perceptions of lung cancer screening in Austrian medical practice. Cancer Medicine, 13(23), Article e70453. https://doi.org/10.1002/cam4.70453

Dau, P. H., Rumpel, M., & Wegwarth, O. (2024). Krebsfrüherkennungen: Die Kommunikation von Nutzen und Schaden. InFo Hämatologie + Onkologie, 27(9), 10–13. https://doi.org/10.1007/s15004-024-0696-9

Franzen, D., Müller-Birn, C., & Wegwarth, O. (2024). Communicating the privacy-utility trade-off: Supporting informed data donation with privacy decision interfaces for differential privacy. Proceedings of the ACM on Human-Computer Interaction, 8(CSCW1), Article 32. https://doi.org/10.1145/3637309

Giese, H., Neth, H., Wegwarth, O., Gaissmaier, W., & Stok, F. M. (2024). How to convince the vaccine-hesitant? An ease-of-access nudge, but not risk-related information increased Covid vaccination-related behaviors in the unvaccinated. Applied Psychology: Health and Well-Being, 16(1), 198–215. https://doi.org/10.1111/aphw.12479

Giese, H., Wegwarth, O., & Gaissmaier, W. (2024). Effects of experimental, network-based social circle norm feedback on studying behavior and alcohol consumption. Applied Psychology: Health and Well-Being, 16(4), 2116–2128. https://doi.org/10.1111/aphw.12582

Rumpel, M., Dau, P. H., & Wegwarth, O. (2024). Überlebensraten im Kontext von Früherkennung: Ein invalides Maß. InFo Hämatologie + Onkologie, 27(9), 14–17. https://doi.org/10.1007/s15004-024-0695-x

Rumpel, M., Dau, P. H., & Wegwarth, O. (2024). Positiver Screeningbefund: "Habe ich nun Krebs?". InFo Hämatologie + Onkologie, 27(9), 18–21. https://doi.org/10.1007/s15004-024-0703-1

Wegwarth, O. (2024). "Wir brauchen eine Revolution zur Förderung transparenter Informationen" [Editorial]. InFo Hämatologie + Onkologie, 27(9), 3. https://doi.org/10.1007/s15004-024-0697-8

Wegwarth, O., Hertwig, R., Giese, H., & Fineberg, H. V. (2024). The impact of nontransparent health communication during the COVID-19 pandemic on vaccine-hesitant people's perception of vaccines. Frontiers in Public Health, 11, Article 1256829. https://doi.org/10.3389/fpubh.2023.1256829

Wegwarth, O., Hoffmann, T. C., Goldacre, B., Spies, C., & Giese, H. A. (2024). General practitioners' risk literacy and real-world prescribing of potentially hazardous drugs: A cross-sectional study. BMJ Quality & Safety, 33(10), 634–641. https://doi.org/10.1136/bmjqs-2023-016979

Wegwarth, O., & Michl, S. (2024). Transparente medizinische Risikokommunikation: Eine ethische Verantwortung? Zeitschrift für medizinische Ethik, 70(4), 470–491. https://doi.org/10.30965/29498570-20240096

Wegwarth, O. (2024). Exkurs: Eine Frage des Vertrauens. Transparenz in der Gesundheitskommunikation. In C. Straub (Ed.), Transparenz im Gesundheitswesen: Vertrauen. Wissen. Partizipation. (pp. 31–36). Medizinisch Wissenschaftliche Verlagsgesellschaft.

Giese, H., Gaissmaier, W., Kuss, O., & Wegwarth, O. (2024). Transparency in risk communication of trials with time-to-event outcomes in medicine: A randomized trial. OSF Preprints, December 17, 2024. https://doi.org/10.31219/osf.io/py9rc